Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesGetinge Industrier AB

Getinge Industrier AB

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
28.105 USD 0.00(0%)
Last update at 2026-11-09T21:00:00Z
VOLUME
100
Market Cap
6653.99M
P/E
24.19

Momentum Score

…

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
28.06
Low
28.11
High
52 Week Price Range
18.84
Low
25.98
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Getinge Industrier AB is a Swedish medical-technology company supplying equipment and services for operating rooms, intensive care and infection control and serving hospitals and life-science customers globally. Long-term growth could be supported by demographic-driven demand, rising healthcare spending and recurring aftermarket services and consumables. Its broad product portfolio and installed-service network appears positioned to benefit from secular healthcare trends.
Investors should monitor regulatory and product-liability exposure, reimbursement and hospital capital-spending cyclicality, competitive and execution risk, and supply-chain and currency volatility.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
28.11
Dividend Yield
-
Revenue TTM
35854.00M
Revenue Per Share
131.64
Gross Profit TTM
16905.00M
Debt / Equity
0.37
ROE
8.95%
Net Debt
7483.00M
ROCE
9.63%
Diluted EPS TTM
1.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 3145.00M 2282.00M 3343.00M 3472.00M 4188.00M
Minority interest -17.00M -16.00M -20.00M -25.00M -31.00M
Net income 2258.00M 1638.00M 2412.00M 2491.00M 2970.00M
Selling general administrative 4182.00M 4240.00M 4315.00M 3516.00M 3337.00M
Selling and marketing expenses 5345.00M 5354.00M 5366.00M 4870.00M 4590.00M
Gross profit 16654.00M 16153.00M 14495.00M 13409.00M 13580.00M
Reconciled depreciation 2250.00M 2421.00M 2185.00M 2027.00M 1814.00M
Ebit 4186.00M 2888.00M 3812.00M 3626.00M 4371.00M
Ebitda 6436.00M 5309.00M 5905.00M 5939.00M 6168.00M
Depreciation and amortization 2250.00M 2421.00M 2093.00M 2313.00M 1797.00M
Operating income 3789.00M 2854.00M 3736.00M 3626.00M 4371.00M
Other operating expenses 31180.00M 31905.00M 28091.00M 24409.00M 22783.00M
Interest expense 484.09M 606.00M 469.00M 205.00M 152.00M
Tax provision 869.00M 628.00M 868.00M 956.00M 1187.00M
Interest income 73.00M 68.00M 123.00M 54.00M 10.00M
Net interest income -644.00M -571.00M -308.00M -174.00M -183.00M
Income tax expense 869.00M 628.00M 915.00M 956.00M 1187.00M
Total revenue 34969.00M 34759.00M 31827.00M 28291.00M 27049.00M
Total operating expenses 12865.00M 13299.00M 10759.00M 9527.00M 9314.00M
Cost of revenue 18315.00M 18606.00M 17332.00M 14882.00M 13469.00M
Total other income expense net -644.00M -572.00M -393.00M -154.00M -183.00M
Net income from continuing ops 2276.00M 1654.00M 2271.00M 2516.00M 3001.00M
Net income applicable to common shares - - - - 2970.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 56505.00M 63918.00M 53586.00M 52032.00M 44555.00M
Intangible assets 7738.13M 9153.00M 2846.00M 4497.00M 4467.00M
Other current assets - 360.00M 1138.00M 1.00M -1.00M
Total liab 27012.00M 30708.00M 23183.00M 21579.00M 19379.00M
Total stockholder equity 29429.00M 33005.00M 30166.00M 30038.00M 24749.00M
Deferred long term liab - - - - 2763.00M
Other current liab 8962.00M 9758.00M 4874.00M 8948.00M 476.00M
Common stock 136.00M 136.00M 136.00M 136.00M 136.00M
Capital stock 136.00M 136.00M 136.00M 136.00M 136.00M
Retained earnings 21504.00M 20328.00M 19861.00M 18796.00M 16579.00M
Other liab - - - - 5273.00M
Good will 25775.45M 30088.00M 24869.00M 22514.00M 19681.00M
Other assets - -1.00M - - 3981.00M
Cash 3401.00M 2961.00M 2728.00M 5676.00M 4076.00M
Total current liabilities 13042.00M 15047.00M 13185.00M 11993.00M 10610.00M
Current deferred revenue - - 2453.00M - 7402.00M
Net debt 7483.00M 7766.00M 5348.00M 148.00M 230.00M
Short term debt 1962.00M 2447.00M 3116.00M 793.00M 811.00M
Short long term debt 1510.00M 1956.00M 2694.00M 410.00M 475.00M
Short long term debt total 10884.00M 10727.00M 8076.00M 5824.00M 4306.00M
Other stockholder equity 7789.00M 6789.00M 10169.00M 11106.00M 8034.00M
Property plant equipment - - - - 4120.00M
Total current assets 17227.00M 18162.00M 16647.00M 19106.00M 15069.00M
Net tangible assets - - - - 3365.00M
Short term investments - - 60.00M - -
Net receivables 7808.00M 8251.00M 6364.00M 7197.00M 6227.00M
Long term debt 7893.00M 6971.00M 3903.00M 4100.00M 2795.00M
Inventory 6018.00M 6590.00M 6416.00M 6232.00M 4767.00M
Accounts payable 2118.00M 2398.00M 2355.00M 2252.00M 1921.00M
Accumulated other comprehensive income - 5752.00M 3380.00M - -
Non currrent assets other -0.00M 34.00M 3954.00M 50.00M -1.00M
Non current assets total 39278.00M 45757.00M 36939.00M 32926.00M 29486.00M
Capital lease obligations 1481.00M 1800.00M 1479.00M 1314.00M 1036.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -4549.00M -1700.00M -1470.00M -1329.00M
Change to liabilities - - - - 0.00M
Total cashflows from investing activities -2782.37M -4549.00M -6543.00M - -1329.00M
Net borrowings 1000.00M 2207.00M 2197.00M - -6378.00M
Total cash from financing activities -719.09M 504.00M 511.00M -500.00M -7237.00M
Change to operating activities - - - - 208.00M
Net income 3789.00M 2854.00M 2412.00M 3626.00M 4371.00M
Change in cash 952.24M 233.00M -2948.00M 1600.00M -1980.00M
Begin period cash flow 2961.00M 2728.00M 5676.00M 4076.00M 6056.00M
End period cash flow 3401.00M 2961.00M 2728.00M 5676.00M 4076.00M
Total cash from operating activities 3712.96M 4577.00M 2957.00M 3367.00M 6560.00M
Depreciation 2250.00M 2421.00M 2093.00M 2027.00M 1814.00M
Other cashflows from investing activities 194.63M 16.00M -776.00M - 316.00M
Dividends paid 1177.81M 1227.00M 1158.00M -1111.00M -858.00M
Change to inventory -465.00M 46.00M -202.00M -998.00M -71.00M
Change to account receivables -218.00M -712.00M -305.00M - 805.00M
Other cashflows from financing activities -541.28M -476.00M -52.00M 1052.00M 780.00M
Change to netincome - - - - 841.00M
Capital expenditures 1235.15M 1309.00M 1353.00M 1136.00M 930.00M
Change in working capital -1187.00M -416.00M -1640.00M -1242.00M 942.00M
Other non cash items -1139.04M -282.00M 92.00M -1044.00M -567.00M
Free cash flow 2477.81M 3268.00M 1604.00M 2231.00M 5630.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GNGBY
Getinge Industrier AB		 -
-%		 28.11 24.19 17.42 1.88 2.08 2.16 11.79
ABT
Abbott Laboratories		 0.24
0.22%		 110.75 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -1.20
1.17%		 101.59 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -1.51
0.46%		 324.22 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -0.98
1.99%		 48.27 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Getinge Industrier AB

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Lindholmspiren 7A, Gothenburg, Sweden, 417 56

46 1 03 35 00 00

https://www.getinge.com

11758

Name Title Year Born
Mr. Mattias Perjos M.Sc. CEO, Pres & Director 1972
Mr. Lars Sandstrom M.Sc. Chief Financial Officer 1972
Mr. Lars Mattsson Head of Investor Relations NA
Ms. Anna Romberg MSc Econ Exec. VP of Legal, Compliance & Governance 1979
Ms. Jeanette Heden Carlsson Exec. VP of Communications & Brand Management 1966
Mr. Magnus Lundback Ph.D. Exec. VP of HR & Sustainability 1969
Dr. Dieter Engel Chief Technology Officer of Surgical Workflows NA
Mr. Carsten Blecker Chief Commercial Officer 1966
Mr. Stephane Le Roy Pres of Surgical Workflows 1977
Ralf Uwe Schmit Corp. Head of Sustainability NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DRUG
CAD 32.00
+23.08%
CHR
CAD 35.50
+7.80%
HG
CAD 4.77
+7.19%
QTWO
CAD 1.73
+7.14%
PET
CAD 23.03
+7.02%
MUX
CAD 18.80
-17.69%
URE
CAD 0.96
-15.04%
WELL
CAD 3.62
-14.82%
ITH
CAD 2.01
-10.67%
SGML
CAD 7.52
-9.94%

Equity Sectors*

  • Basic Materials

    -3.56%

  • Communication Services

    +0.11%

  • Consumer Cyclical

    -0.57%

  • Consumer Defensive

    -0.30%

  • Energy

    +0.19%

  • Financial Services

    -0.06%

  • Healthcare

    -0.37%

  • Industrials

    -0.81%

  • Real Estate

    -0.85%

  • Technology

    -0.12%

  • Utilities

    -0.11%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…